Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 14
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Fresenius Medical Care AG
FMS
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$21.07
-0.14
-0.66%
Últ. Act.: Oct 13, 4:00 PM
$21.37
0.16
0.75%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Privacy Manager
Fresenius Medical Care Financials
Fresenius Medical Care (FMS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.
Benzinga Newsdesk
PRO
Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.870B Est
Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.870 billion estimate.
Benzinga Newsdesk
PRO
Fresenius Medical Care Q1 Adj. EPS $0.53 Misses $0.59 Estimate, Sales $5.401B Miss $5.720B Estimate
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 20.45 percent increase over earnings of $0.44 per share
Benzinga Newsdesk
PRO
Fresenius Medical Care Sees FY2026 Sales $23.764B vs $22.640B Est
Fresenius Medical Care (NYSE:FMS) sees FY2026 sales of $23.764 billion vs $22.640 billion analyst estimate.
Benzinga Newsdesk
